Alcon Share Holder Equity 2019-2022 | ALC
Alcon share holder equity from 2019 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
- Alcon share holder equity for the quarter ending December 31, 2022 was $19.677B, a 2.19% increase year-over-year.
- Alcon share holder equity for 2022 was $19.677B, a 2.19% increase from 2021.
- Alcon share holder equity for 2021 was $19.256B, a 2.31% increase from 2020.
- Alcon share holder equity for 2020 was $18.822B, a 2.49% decline from 2019.
Alcon Annual Share Holder Equity
(Millions of US $) |
| 2022 |
$19,677 |
| 2021 |
$19,256 |
| 2020 |
$18,822 |
| 2019 |
$19,303 |
| 2018 |
$22,639 |
Alcon Quarterly Share Holder Equity
(Millions of US $) |
| 2022-12-31 |
$19,677 |
| 2022-09-30 |
$19,647 |
| 2022-06-30 |
$19,541 |
| 2022-03-31 |
$19,486 |
| 2021-12-31 |
$19,256 |
| 2021-09-30 |
$19,093 |
| 2021-06-30 |
$19,064 |
| 2021-03-31 |
$18,913 |
| 2020-12-31 |
$18,822 |
| 2020-09-30 |
$18,656 |
| 2020-06-30 |
$18,773 |
| 2020-03-31 |
$19,171 |
| 2019-12-31 |
$19,303 |
| 2019-09-30 |
$19,385 |
| 2019-06-30 |
$19,452 |
| 2019-03-31 |
$0 |
| 2018-12-31 |
|
| 2018-09-30 |
$0 |
| 2018-06-30 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$33.478B |
$8.717B |
|
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
|
